PELI2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.915000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.224000E-01
Normal-vs-Stage2
7.926000E-01
Normal-vs-Stage3
6.514200E-01
Normal-vs-Stage4
3.534800E-01
Stage1-vs-Stage2
5.710800E-01
Stage1-vs-Stage3
9.197000E-01
Stage1-vs-Stage4
5.690200E-02
Stage2-vs-Stage3
7.236000E-01
Stage2-vs-Stage4
1.904810E-01
Stage3-vs-Stage4
2.553400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.699800E-01
Normal-vs-AfricanAmerican
7.993200E-01
Normal-vs-Asian
1.686570E-01
Caucasian-vs-AfricanAmerican
3.762000E-01
Caucasian-vs-Asian
1.276960E-01
AfricanAmerican-vs-Asian
9.253900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.503400E-01
Normal-vs-Female
8.235400E-01
Male-vs-Female
6.475800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.653800E-01
Normal-vs-Age(41-60Yrs)
9.372600E-01
Normal-vs-Age(61-80Yrs)
7.173600E-01
Normal-vs-Age(81-100Yrs)
1.325890E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.187800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.360400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.100350E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.271760E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.0724000000012E-05
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.558000E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.052600E-01
Normal-vs-Daily Drinker
6.752800E-01
Normal-vs-Weekly Drinker
8.593400E-01
Normal-vs-Occasional Drinker
9.993800E-01
Normal-vs-Social Drinker
9.159400E-01
Non Drinker-vs-Daily Drinker
6.544200E-01
Non Drinker-vs-Weekly Drinker
4.514400E-01
Non Drinker-vs-Occasional Drinker
2.697000E-01
Non Drinker-vs-Social Drinker
2.310200E-01
Daily Drinker-vs-Weekly Drinker
7.099200E-01
Daily Drinker-vs-Occasional Drinker
4.860200E-01
Daily Drinker-vs-Social Drinker
3.838800E-01
Weekly Drinker-vs-Occasional Drinker
7.821000E-01
Weekly Drinker-vs-Social Drinker
6.574200E-01
Occasional Drinker-vs-Social Drinker
8.543600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.462200E-01
Normal-vs-Grade 2
3.107800E-01
Normal-vs-Grade 3
3.937800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.599600E-01
Grade 1-vs-Grade 3
9.294800E-01
Grade 1-vs-Grade 4
4.462200E-01
Grade 2-vs-Grade 3
7.331800E-01
Grade 2-vs-Grade 4
3.107800E-01
Grade 3-vs-Grade 4
3.937800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.954600E-01
Normal-vs-NonDiabetic
8.127400E-01
Diabetic-vs-NonDiabetic
5.025000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.418200E-02
Normal-vs-NoPancreatitis
8.369600E-01
Pancreatitis-vs-NoPancreatitis
9.202600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.662400E-01
Normal-vs-N1
8.302400E-01
N0-vs-N1
6.472000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.066000E-01
Normal-vs-TP53-NonMutant
7.408600E-01
TP53-Mutant-vs-TP53-NonMutant
5.306600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
